GARCINIA CAMBOGIA 500
Natural health product licensed in Canada
- Licence holder
- SAGA Sciences Canada, Inc.
- NPN or DIN-HM
- 80047153
- Status
- Active licence
- Licence date
- 12 December 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Substance interdite
Contains the plant Garcinia cambogia (Garcinia gummi-gutta). In France, importing and placing food supplements containing it on the market are suspended until 17 April 2027 (arrêté du 16 avril 2026).
arrêté du 16 avril 2026 (JORFTEXT000053907152). French orders suspending food supplements containing a plant (Official Journal), checked against the text, retrieved 23 October 2026.
Order published in the French Official Journal, read on Légifrance.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Garcinia gummi-gutta Source : Pelure (fruit) Extraction ratio : 10:1 Dry plant equivalent : 5,000 mg Potency : 60 % Hydroxycitric acid | 500 mg | Not calculated |
| Garcinia gummi-gutta Source : Écorce du fruit Extraction ratio : 10:1 Dry plant equivalent : 5,000 mg Potency : 60 % Hydroxycitric acid | 500 mg | Not calculated |
| Panax ginseng Source : Racine | 1.25 mg | Not calculated |
| Astragalus membranaceus Source : Racine | 1.25 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 3 Capsule | 2 days |
Uses authorised in Canada
Could help to temporarily increase satiety / feeling of fullness.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner prior to use if you are taking antidepressant medications. Consult a health care practitioner prior to use if you are taking blood thinners or digoxin. Consult a health care practitioner prior to use if you have an auto-immune disorder.
- Effets indésirables connus
Some people may experience insomnia, anxiety, or headaches, in which case, discontinue use.
Source
Official Health Canada record, licence 80047153
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.